Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2024 Revenue
$45.0B
▼ 2% vs FY2023 ($45.9B)
Source: Annual report / company filing
Bristol-Myers Squibb Company reported $45.0B in revenue for fiscal year 2024. This represents a decline of 2% compared to the 2023 figure of $45.9B. In 2025, revenue increased to $48.2B.
Net revenues declined 2.0% to $45.0 billion, with Eliquis at roughly $13.0 billion and Opdivo near $9.0 billion cushioning continued patent-driven pressure on legacy drugs.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $48.2B | $2.9B | +7.1% |
| FY2024 | $45.0B | — | -2.0% |
| FY2023 | $45.9B | — | -0.4% |
| FY2022 | $46.1B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.